Southland Equity Partners LLC Novartis Ag Transaction History
Southland Equity Partners LLC
- $430 Billion
- Q1 2025
A detailed history of Southland Equity Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Southland Equity Partners LLC holds 3,434 shares of NVS stock, worth $374,134. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,434
Previous 3,380
1.6%
Holding current value
$374,134
Previous $329 Million
16.39%
% of portfolio
0.09%
Previous 0.08%
Shares
14 transactions
Others Institutions Holding NVS
# of Institutions
1,518Shares Held
132MCall Options Held
1.4MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.13 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$938 Million0.25% of portfolio
-
Morgan Stanley New York, NY6.87MShares$748 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$608 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $234B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...